Vanderbilt Therapeutics (VT) CRS (3652) — Nashville, Tennessee

Vanderbilt Therapeutics (VT) CRS (3652) is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Therapeutics (VT) CRS (3652) has participated in 2 clinical trials.

Therapeutic areas: HIV Infections, Hepatitis C, HIV-1-infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Therapeutics (VT) CRS (3652)?

Vanderbilt Therapeutics (VT) CRS (3652) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Therapeutics (VT) CRS (3652) conducted?

Vanderbilt Therapeutics (VT) CRS (3652) has 2 clinical trials on record. Their work covers HIV Infections, Hepatitis C, HIV-1-infection.

Is Vanderbilt Therapeutics (VT) CRS (3652) accredited by Crixeo Health?

Vanderbilt Therapeutics (VT) CRS (3652) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Therapeutics (VT) CRS (3652)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.